Special Considerations and Clinical Management of HIV-Infected Drug Users

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • 3,4 methylenedioxy-methamphetamine (Ecstasy) has mild stimulatory effects on the central nervous system as well as hallucinogenic and psychedelic properties
  • Long-term use has been associated with cognitive impairment, depression, anxiety, and insomnia[Black 2009; Vanden Eede 2012; Kaye 2009; Rogers 2009; Wu 2009a; Wu 2009b]

Action required

Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.